In Colorectal Cancer, Chemo-Induced Volume Elevation Linked with Postoperative Complications

Share this content:

the Cancer Therapy Advisor take:

According to a new study published in the Journal of the American College of Surgeons, researchers have found that having liver metastases and receiving chemotherapy are associated with higher splenic volume in patients with metastatic colorectal cancer, and the splenic volume increase is independently linked with major postoperative complications following hepatic resection.

For the study, researchers enrolled 80 patients with metastatic colorectal cancer and liver metastases who underwent hepatic resection. Of those, half received chemotherapy for 6 months before surgery while the other half did not receive preoperative chemotherapy. The patients who received preoperative chemotherapy were also compared to a group of 40 patients with benign disease who underwent cholecystectomy and a group of 40 patients with untreated non-metastatic colorectal cancer.

Results showed that the study group had significantly higher splenic volumes compared with the patients with benign disease (p < 0.001) and the patients with non-metastatic disease (p < 0.05) before chemotherapy. After 6 months of chemotherapy, the study group's splenic volumes were even higher, and the elevation was linked with any complication during surgery (p < 0.01) and major postoperative complications (p < 0.05).

Furthermore, patients with a 39% or higher increase in splenic volume were statistically significantly more likely to develop major complications after hepatic resection (p < 0.01). Of note, the researchers found no association between splenic volume increase and change in platelet count.

In Metastatic Colorectal Cancer, Chemo-Induced Splenic Volume Elevation Linked With Major Postoperat
Splenic volume increase is independently linked with major postoperative complications following hepatic resection.
The present study investigates the relationship between change in splenic volume after preoperative chemotherapy and development of postoperative complications. In patients with colorectal cancer liver metastases (CRCLM), the presence of liver metastases and chemotherapy is associated with higher splenic volume.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs